Boston Scientific (BSX) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $0.47.
- Boston Scientific's Debt to Equity fell 431.59% to $0.47 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.47, marking a year-over-year decrease of 431.59%. This contributed to the annual value of $0.47 for FY2025, which is 431.59% down from last year.
- Boston Scientific's Debt to Equity amounted to $0.47 in Q4 2025, which was down 431.59% from $0.49 recorded in Q3 2025.
- In the past 5 years, Boston Scientific's Debt to Equity registered a high of $0.58 during Q1 2021, and its lowest value of $0.47 during Q3 2023.
- In the last 5 years, Boston Scientific's Debt to Equity had a median value of $0.51 in 2022 and averaged $0.51.
- Per our database at Business Quant, Boston Scientific's Debt to Equity surged by 1742.98% in 2021 and then plummeted by 1182.43% in 2022.
- Over the past 5 years, Boston Scientific's Debt to Equity (Quarter) stood at $0.55 in 2021, then decreased by 6.77% to $0.51 in 2022, then decreased by 8.34% to $0.47 in 2023, then rose by 4.79% to $0.49 in 2024, then dropped by 4.32% to $0.47 in 2025.
- Its last three reported values are $0.47 in Q4 2025, $0.49 for Q3 2025, and $0.51 during Q2 2025.